1 Report Business Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Acute Migraine Treatments Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 1.2.2 Drugs 1.2.3 Patches 1.2.4 Others 1.3 Market by Application 1.3.1 Global Acute Migraine Treatments Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 1.3.2 Hospital Pharmacies 1.3.3 Drug Stores 1.3.4 Retail Pharmacies 1.3.5 Online Pharmacies 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Acute Migraine Treatments Market Perspective (2017-2028) 2.2 Acute Migraine Treatments Growth Trends by Region 2.2.1 Acute Migraine Treatments Market Size by Region: 2017 VS 2021 VS 2028 2.2.2 Acute Migraine Treatments Historic Market Size by Region (2017-2022) 2.2.3 Acute Migraine Treatments Forecasted Market Size by Region (2023-2028) 2.3 Acute Migraine Treatments Market Dynamics 2.3.1 Acute Migraine Treatments Industry Trends 2.3.2 Acute Migraine Treatments Market Drivers 2.3.3 Acute Migraine Treatments Market Challenges 2.3.4 Acute Migraine Treatments Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Acute Migraine Treatments Players by Revenue 3.1.1 Global Top Acute Migraine Treatments Players by Revenue (2017-2022) 3.1.2 Global Acute Migraine Treatments Revenue Market Share by Players (2017-2022) 3.2 Global Acute Migraine Treatments Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Acute Migraine Treatments Revenue 3.4 Global Acute Migraine Treatments Market Concentration Ratio 3.4.1 Global Acute Migraine Treatments Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Acute Migraine Treatments Revenue in 2021 3.5 Acute Migraine Treatments Key Players Head office and Area Served 3.6 Key Players Acute Migraine Treatments Product Solution and Service 3.7 Date of Enter into Acute Migraine Treatments Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Acute Migraine Treatments Breakdown Data by Type 4.1 Global Acute Migraine Treatments Historic Market Size by Type (2017-2022) 4.2 Global Acute Migraine Treatments Forecasted Market Size by Type (2023-2028) 5 Acute Migraine Treatments Breakdown Data by Application 5.1 Global Acute Migraine Treatments Historic Market Size by Application (2017-2022) 5.2 Global Acute Migraine Treatments Forecasted Market Size by Application (2023-2028) 6 North America 6.1 North America Acute Migraine Treatments Market Size (2017-2028) 6.2 North America Acute Migraine Treatments Market Size by Type 6.2.1 North America Acute Migraine Treatments Market Size by Type (2017-2022) 6.2.2 North America Acute Migraine Treatments Market Size by Type (2023-2028) 6.2.3 North America Acute Migraine Treatments Market Share by Type (2017-2028) 6.3 North America Acute Migraine Treatments Market Size by Application 6.3.1 North America Acute Migraine Treatments Market Size by Application (2017-2022) 6.3.2 North America Acute Migraine Treatments Market Size by Application (2023-2028) 6.3.3 North America Acute Migraine Treatments Market Share by Application (2017-2028) 6.4 North America Acute Migraine Treatments Market Size by Country 6.4.1 North America Acute Migraine Treatments Market Size by Country (2017-2022) 6.4.2 North America Acute Migraine Treatments Market Size by Country (2023-2028) 6.4.3 U.S. 6.4.4 Canada 7 Europe 7.1 Europe Acute Migraine Treatments Market Size (2017-2028) 7.2 Europe Acute Migraine Treatments Market Size by Type 7.2.1 Europe Acute Migraine Treatments Market Size by Type (2017-2022) 7.2.2 Europe Acute Migraine Treatments Market Size by Type (2023-2028) 7.2.3 Europe Acute Migraine Treatments Market Share by Type (2017-2028) 7.3 Europe Acute Migraine Treatments Market Size by Application 7.3.1 Europe Acute Migraine Treatments Market Size by Application (2017-2022) 7.3.2 Europe Acute Migraine Treatments Market Size by Application (2023-2028) 7.3.3 Europe Acute Migraine Treatments Market Share by Application (2017-2028) 7.4 Europe Acute Migraine Treatments Market Size by Country 7.4.1 Europe Acute Migraine Treatments Market Size by Country (2017-2022) 7.4.2 Europe Acute Migraine Treatments Market Size by Country (2023-2028) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Acute Migraine Treatments Market Size (2017-2028) 8.2 Asia-Pacific Acute Migraine Treatments Market Size by Type 8.2.1 Asia-Pacific Acute Migraine Treatments Market Size by Type (2017-2022) 8.2.2 Asia-Pacific Acute Migraine Treatments Market Size by Type (2023-2028) 8.2.3 Asia-Pacific Acute Migraine Treatments Market Share by Type (2017-2028) 8.3 Asia-Pacific Acute Migraine Treatments Market Size by Application 8.3.1 Asia-Pacific Acute Migraine Treatments Market Size by Application (2017-2022) 8.3.2 Asia-Pacific Acute Migraine Treatments Market Size by Application (2023-2028) 8.3.3 Asia-Pacific Acute Migraine Treatments Market Share by Application (2017-2028) 8.4 Asia-Pacific Acute Migraine Treatments Market Size by Region 8.4.1 Asia-Pacific Acute Migraine Treatments Market Size by Region (2017-2022) 8.4.2 Asia-Pacific Acute Migraine Treatments Market Size by Region (2023-2028) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America Acute Migraine Treatments Market Size (2017-2028) 9.2 Latin America Acute Migraine Treatments Market Size by Type 9.2.1 Latin America Acute Migraine Treatments Market Size by Type (2017-2022) 9.2.2 Latin America Acute Migraine Treatments Market Size by Type (2023-2028) 9.2.3 Latin America Acute Migraine Treatments Market Share by Type (2017-2028) 9.3 Latin America Acute Migraine Treatments Market Size by Application 9.3.1 Latin America Acute Migraine Treatments Market Size by Application (2017-2022) 9.3.2 Latin America Acute Migraine Treatments Market Size by Application (2023-2028) 9.3.3 Latin America Acute Migraine Treatments Market Share by Application (2017-2028) 9.4 Latin America Acute Migraine Treatments Market Size by Country 9.4.1 Latin America Acute Migraine Treatments Market Size by Country (2017-2022) 9.4.2 Latin America Acute Migraine Treatments Market Size by Country (2023-2028) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Acute Migraine Treatments Market Size (2017-2028) 10.2 Middle East & Africa Acute Migraine Treatments Market Size by Type 10.2.1 Middle East & Africa Acute Migraine Treatments Market Size by Type (2017-2022) 10.2.2 Middle East & Africa Acute Migraine Treatments Market Size by Type (2023-2028) 10.2.3 Middle East & Africa Acute Migraine Treatments Market Share by Type (2017-2028) 10.3 Middle East & Africa Acute Migraine Treatments Market Size by Application 10.3.1 Middle East & Africa Acute Migraine Treatments Market Size by Application (2017-2022) 10.3.2 Middle East & Africa Acute Migraine Treatments Market Size by Application (2023-2028) 10.3.3 Middle East & Africa Acute Migraine Treatments Market Share by Application (2017-2028) 10.4 Middle East & Africa Acute Migraine Treatments Market Size by Country 10.4.1 Middle East & Africa Acute Migraine Treatments Market Size by Country (2017-2022) 10.4.2 Middle East & Africa Acute Migraine Treatments Market Size by Country (2023-2028) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Amgen 11.1.1 Amgen Company Details 11.1.2 Amgen Business Overview 11.1.3 Amgen Acute Migraine Treatments Introduction 11.1.4 Amgen Revenue in Acute Migraine Treatments Business (2017-2022) 11.1.5 Amgen Recent Developments 11.2 Pfizer 11.2.1 Pfizer Company Details 11.2.2 Pfizer Business Overview 11.2.3 Pfizer Acute Migraine Treatments Introduction 11.2.4 Pfizer Revenue in Acute Migraine Treatments Business (2017-2022) 11.2.5 Pfizer Recent Developments 11.3 Novartis 11.3.1 Novartis Company Details 11.3.2 Novartis Business Overview 11.3.3 Novartis Acute Migraine Treatments Introduction 11.3.4 Novartis Revenue in Acute Migraine Treatments Business (2017-2022) 11.3.5 Novartis Recent Developments 11.4 Eli Lily 11.4.1 Eli Lily Company Details 11.4.2 Eli Lily Business Overview 11.4.3 Eli Lily Acute Migraine Treatments Introduction 11.4.4 Eli Lily Revenue in Acute Migraine Treatments Business (2017-2022) 11.4.5 Eli Lily Recent Developments 11.5 AstraZeneca 11.5.1 AstraZeneca Company Details 11.5.2 AstraZeneca Business Overview 11.5.3 AstraZeneca Acute Migraine Treatments Introduction 11.5.4 AstraZeneca Revenue in Acute Migraine Treatments Business (2017-2022) 11.5.5 AstraZeneca Recent Developments 11.6 Teva Pharmaceutical 11.6.1 Teva Pharmaceutical Company Details 11.6.2 Teva Pharmaceutical Business Overview 11.6.3 Teva Pharmaceutical Acute Migraine Treatments Introduction 11.6.4 Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2017-2022) 11.6.5 Teva Pharmaceutical Recent Developments 11.7 Allergan 11.7.1 Allergan Company Details 11.7.2 Allergan Business Overview 11.7.3 Allergan Acute Migraine Treatments Introduction 11.7.4 Allergan Revenue in Acute Migraine Treatments Business (2017-2022) 11.7.5 Allergan Recent Developments 11.8 Abbott 11.8.1 Abbott Company Details 11.8.2 Abbott Business Overview 11.8.3 Abbott Acute Migraine Treatments Introduction 11.8.4 Abbott Revenue in Acute Migraine Treatments Business (2017-2022) 11.8.5 Abbott Recent Developments 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Author Details 13.3 Disclaimer

List of Tables Table 1. Global Acute Migraine Treatments Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028 Table 2. Key Players of Drugs Table 3. Key Players of Patches Table 4. Key Players of Others Table 5. Global Acute Migraine Treatments Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028 Table 6. Global Acute Migraine Treatments Market Size by Region (US$ Million): 2017 VS 2021 VS 2028 Table 7. Global Acute Migraine Treatments Market Size by Region (2017-2022) & (US$ Million) Table 8. Global Acute Migraine Treatments Market Share by Region (2017-2022) Table 9. Global Acute Migraine Treatments Forecasted Market Size by Region (2023-2028) & (US$ Million) Table 10. Global Acute Migraine Treatments Market Share by Region (2023-2028) Table 11. Acute Migraine Treatments Market Trends Table 12. Acute Migraine Treatments Market Drivers Table 13. Acute Migraine Treatments Market Challenges Table 14. Acute Migraine Treatments Market Restraints Table 15. Global Acute Migraine Treatments Revenue by Players (2017-2022) & (US$ Million) Table 16. Global Acute Migraine Treatments Revenue Share by Players (2017-2022) Table 17. Global Top Acute Migraine Treatments by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Treatments as of 2021) Table 18. Ranking of Global Top Acute Migraine Treatments Companies by Revenue (US$ Million) in 2021 Table 19. Global 5 Largest Players Market Share by Acute Migraine Treatments Revenue (CR5 and HHI) & (2017-2022) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Acute Migraine Treatments Product Solution and Service Table 22. Date of Enter into Acute Migraine Treatments Market Table 23. Mergers & Acquisitions, Expansion Plans Table 24. Global Acute Migraine Treatments Market Size by Type (2017-2022) & (US$ Million) Table 25. Global Acute Migraine Treatments Revenue Market Share by Type (2017-2022) Table 26. Global Acute Migraine Treatments Forecasted Market Size by Type (2023-2028) & (US$ Million) Table 27. Global Acute Migraine Treatments Revenue Market Share by Type (2023-2028) Table 28. Global Acute Migraine Treatments Market Size by Application (2017-2022) & (US$ Million) Table 29. Global Acute Migraine Treatments Revenue Share by Application (2017-2022) Table 30. Global Acute Migraine Treatments Forecasted Market Size by Application (2023-2028) & (US$ Million) Table 31. Global Acute Migraine Treatments Revenue Share by Application (2023-2028) Table 32. North America Acute Migraine Treatments Market Size by Type (2017-2022) & (US$ Million) Table 33. North America Acute Migraine Treatments Market Size by Type (2023-2028) & (US$ Million) Table 34. North America Acute Migraine Treatments Market Size by Application (2017-2022) & (US$ Million) Table 35. North America Acute Migraine Treatments Market Size by Application (2023-2028) & (US$ Million) Table 36. North America Acute Migraine Treatments Market Size by Country (2017-2022) & (US$ Million) Table 37. North America Acute Migraine Treatments Market Size by Country (2023-2028) & (US$ Million) Table 38. Europe Acute Migraine Treatments Market Size by Type (2017-2022) & (US$ Million) Table 39. Europe Acute Migraine Treatments Market Size by Type (2023-2028) & (US$ Million) Table 40. Europe Acute Migraine Treatments Market Size by Application (2017-2022) & (US$ Million) Table 41. Europe Acute Migraine Treatments Market Size by Application (2023-2028) & (US$ Million) Table 42. Europe Acute Migraine Treatments Market Size by Country (2017-2022) & (US$ Million) Table 43. Europe Acute Migraine Treatments Market Size by Country (2023-2028) & (US$ Million) Table 44. Asia Pacific Acute Migraine Treatments Market Size by Type (2017-2022) & (US$ Million) Table 45. Asia Pacific Acute Migraine Treatments Market Size by Type (2023-2028) & (US$ Million) Table 46. Asia Pacific Acute Migraine Treatments Market Size by Application (2017-2022) & (US$ Million) Table 47. Asia Pacific Acute Migraine Treatments Market Size by Application (2023-2028) & (US$ Million) Table 48. Asia Pacific Acute Migraine Treatments Market Size by Region (2017-2022) & (US$ Million) Table 49. Asia Pacific Acute Migraine Treatments Market Size by Region (2023-2028) & (US$ Million) Table 50. Latin America Acute Migraine Treatments Market Size by Type (2017-2022) & (US$ Million) Table 51. Latin America Acute Migraine Treatments Market Size by Type (2023-2028) & (US$ Million) Table 52. Latin America Acute Migraine Treatments Market Size by Application (2017-2022) & (US$ Million) Table 53. Latin America Acute Migraine Treatments Market Size by Application (2023-2028) & (US$ Million) Table 54. Latin America Acute Migraine Treatments Market Size by Country (2017-2022) & (US$ Million) Table 55. Latin America Acute Migraine Treatments Market Size by Country (2023-2028) & (US$ Million) Table 56. Middle East and Africa Acute Migraine Treatments Market Size by Type (2017-2022) & (US$ Million) Table 57. Middle East and Africa Acute Migraine Treatments Market Size by Type (2023-2028) & (US$ Million) Table 58. Middle East and Africa Acute Migraine Treatments Market Size by Application (2017-2022) & (US$ Million) Table 59. Middle East and Africa Acute Migraine Treatments Market Size by Application (2023-2028) & (US$ Million) Table 60. Middle East and Africa Acute Migraine Treatments Market Size by Country (2017-2022) & (US$ Million) Table 61. Middle East and Africa Acute Migraine Treatments Market Size by Country (2023-2028) & (US$ Million) Table 62. Amgen Company Details Table 63. Amgen Business Overview Table 64. Amgen Acute Migraine Treatments Product Table 65. Amgen Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 66. Amgen Recent Developments Table 67. Pfizer Company Details Table 68. Pfizer Business Overview Table 69. Pfizer Acute Migraine Treatments Product Table 70. Pfizer Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 71. Pfizer Recent Developments Table 72. Novartis Company Details Table 73. Novartis Business Overview Table 74. Novartis Acute Migraine Treatments Product Table 75. Novartis Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 76. Novartis Recent Developments Table 77. Eli Lily Company Details Table 78. Eli Lily Business Overview Table 79. Eli Lily Acute Migraine Treatments Product Table 80. Eli Lily Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 81. Eli Lily Recent Developments Table 82. AstraZeneca Company Details Table 83. AstraZeneca Business Overview Table 84. AstraZeneca Acute Migraine Treatments Product Table 85. AstraZeneca Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 86. AstraZeneca Recent Developments Table 87. Teva Pharmaceutical Company Details Table 88. Teva Pharmaceutical Business Overview Table 89. Teva Pharmaceutical Acute Migraine Treatments Product Table 90. Teva Pharmaceutical Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 91. Teva Pharmaceutical Recent Developments Table 92. Allergan Company Details Table 93. Allergan Business Overview Table 94. Allergan Acute Migraine Treatments Product Table 95. Allergan Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 96. Allergan Recent Developments Table 97. Abbott Company Details Table 98. Abbott Business Overview Table 99. Abbott Acute Migraine Treatments Product Table 100. Abbott Revenue in Acute Migraine Treatments Business (2017-2022) & (US$ Million) Table 101. Abbott Recent Developments Table 102. Research Programs/Design for This Report Table 103. Key Data Information from Secondary Sources Table 104. Key Data Information from Primary Sources List of Figures Figure 1. Global Acute Migraine Treatments Market Share by Type: 2021 VS 2028 Figure 2. Drugs Features Figure 3. Patches Features Figure 4. Others Features Figure 5. Global Acute Migraine Treatments Market Share by Application: 2021 VS 2028 Figure 6. Hospital Pharmacies Case Studies Figure 7. Drug Stores Case Studies Figure 8. Retail Pharmacies Case Studies Figure 9. Online Pharmacies Case Studies Figure 10. Acute Migraine Treatments Report Years Considered Figure 11. Global Acute Migraine Treatments Market Size (US$ Million), Year-over-Year: 2017-2028 Figure 12. Global Acute Migraine Treatments Market Size, (US$ Million), 2017 VS 2021 VS 2028 Figure 13. Global Acute Migraine Treatments Market Share by Region: 2021 VS 2028 Figure 14. Global Acute Migraine Treatments Market Share by Players in 2021 Figure 15. Global Top Acute Migraine Treatments Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Migraine Treatments as of 2021) Figure 16. The Top 10 and 5 Players Market Share by Acute Migraine Treatments Revenue in 2021 Figure 17. North America Acute Migraine Treatments Market Size YoY (2017-2028) & (US$ Million) Figure 18. North America Acute Migraine Treatments Market Size Market Share by Type (2017-2028) Figure 19. North America Acute Migraine Treatments Market Size Market Share by Application (2017-2028) Figure 20. North America Acute Migraine Treatments Market Size Share by Country (2017-2028) Figure 21. United States Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 22. Canada Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 23. Europe Acute Migraine Treatments Market Size YoY (2017-2028) & (US$ Million) Figure 24. Europe Acute Migraine Treatments Market Size Market Share by Type (2017-2028) Figure 25. Europe Acute Migraine Treatments Market Size Market Share by Application (2017-2028) Figure 26. Europe Acute Migraine Treatments Market Size Share by Country (2017-2028) Figure 27. Germany Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 28. France Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 29. U.K. Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 30. Italy Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 31. Russia Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 32. Nordic Countries Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 33. Asia-Pacific Acute Migraine Treatments Market Size YoY (2017-2028) & (US$ Million) Figure 34. Asia Pacific Acute Migraine Treatments Market Size Market Share by Type (2017-2028) Figure 35. Asia Pacific Acute Migraine Treatments Market Size Market Share by Application (2017-2028) Figure 36. Asia Pacific Acute Migraine Treatments Market Size Share by Region (2017-2028) Figure 37. China Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 38. Japan Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 39. South Korea Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 40. Southeast Asia Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 41. India Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 42. Australia Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) List of Figures Figure 43. Latin America Acute Migraine Treatments Market Size YoY (2017-2028) & (US$ Million) Figure 44. Latin America Acute Migraine Treatments Market Size Market Share by Type (2017-2028) Figure 45. Latin America Acute Migraine Treatments Market Size Market Share by Application (2017-2028) Figure 46. Latin America Acute Migraine Treatments Market Size Share by Country (2017-2028) Figure 47. Mexico Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 48. Brazil Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 49. Middle East & Africa Acute Migraine Treatments Market Size YoY (2017-2028) & (US$ Million) Figure 50. Middle East and Africa Acute Migraine Treatments Market Size Market Share by Type (2017-2028) Figure 51. Middle East and Africa Acute Migraine Treatments Market Size Market Share by Application (2017-2028) Figure 52. Middle East and Africa Acute Migraine Treatments Market Size Share by Country (2017-2028) Figure 53. Turkey Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 54. Saudi Arabia Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 55. UAE Acute Migraine Treatments Market Size YoY Growth (2017-2028) & (US$ Million) Figure 56. Amgen Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 57. Pfizer Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 58. Novartis Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 59. Eli Lily Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 60. AstraZeneca Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 61. Teva Pharmaceutical Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 62. Allergan Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 63. Abbott Revenue Growth Rate in Acute Migraine Treatments Business (2017-2022) Figure 64. Bottom-up and Top-down Approaches for This Report Figure 65. Data Triangulation Figure 66. Key Executives Interviewed

Amgen Pfizer Novartis Eli Lily AstraZeneca Teva Pharmaceutical Allergan Abbott